ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

0RAM Vistin Pharma Asa

11.25
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vistin Pharma Asa LSE:0RAM London Ordinary Share NO0010734122 VISTIN PHARMA ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.25 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 438.33M 45.64M 1.0293 10.93 498.88M

Vistin Pharma ASA: Invitation to Q4 2023 conference call

09/02/2024 9:00am

UK Regulatory


Vistin Pharma Asa (LSE:0RAM)
Historical Stock Chart


From Feb 2024 to May 2024

Click Here for more Vistin Pharma Asa Charts.
Vistin Pharma ASA: Invitation to Q4 2023 conference call

Oslo, Norway, 9 February 2024

Vistin Pharma ASA will release its fourth quarter and preliminary 2023 results on Friday 16th of February 2024. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Friday 16th of February at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in English.

The fourth quarter conference call will be available via web and audio through the following access points:

Webcast:
https://edge.media-server.com/mmc/p/zfievj3m

Telephone conference (online registration):
https://register.vevent.com/register/BI4f66989ce55146f7ba76754c37cdec44 

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com


About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.



1 Year Vistin Pharma Asa Chart

1 Year Vistin Pharma Asa Chart

1 Month Vistin Pharma Asa Chart

1 Month Vistin Pharma Asa Chart

Your Recent History

Delayed Upgrade Clock